CERTAIN FOREIGN PAYMENTS Sample Clauses

CERTAIN FOREIGN PAYMENTS. If governmental regulations prevent remittance from any foreign country of any amounts due under Section 7.4 with respect to that country, Allergan shall so notify ASTI in writing, and the obligation under this Agreement to make payments with respect to sales in that country shall be suspended (but the amounts due but not paid shall continue to accrue) until such remittances are possible. ASTI shall have the right, upon written notice to Allergan, to receive payment in any such country in the local currency.

CERTAIN FOREIGN PAYMENTS. If governmental regulations prevent remittance from any foreign country of any amounts due under Section 3.2 in respect of that country, BioChem, BV or TII shall so notify CliniChem in writing, and the obligation under this Agreement to make payments with respect to sales in that country shall be suspended (but the amounts due but not paid shall continue to accrue) until such remittances are possible. CliniChem shall have the right, upon written notice to BioChem, BV or TII, to receive payment in any such country in the local currency.

CERTAIN FOREIGN PAYMENTS. If governmental regulations prevent remittance from any foreign country of any amounts due under Section 3.1 in respect of that country, ALZA shall so notify TDC in writing, and the obligation under this Agreement to make payments in respect of sales in that country shall be suspended (but the amounts due but not paid shall continue to accrue) until such remittances are possible. TDC shall have the right, upon written notice to ALZA, to receive payment in any such country in the local currency.

CERTAIN FOREIGN PAYMENTS. If governmental regulations prevent remittance from any foreign country of amounts due under Section 3 in respect of that country, Cetus shall so notify the Limited Partner in writing, and subject to the remainder of this Section 6.2, the obligation under this Agreement to make payments in respect of sales in that country shall be suspended (but the amounts due but not paid shall continue to accrue) until such remittances are possible; provided, however, that to the extent Cetus invests its own blocked funds in passive investments in such country or liquidates its own blocked funds at available rates, Cetus shall do the same with the Limited Partner's blocked funds. In addition, on or before December 31 of each calendar year. Cetus shall liquidate any blocked funds of the Limited Partner at available rates and pay any amounts received on liquidation to the Limited Partner. Cetus shall in any event liquidate all such amounts and pay all amounts received as soon as practicable after December 31, 2001. All payments by Cetus under this Section 6.2 shall be deemed to be payment in full of the amounts so paid or liquidated, and Cetus shall have no liability to the Limited Partner for any actions taken in accordance with this Section 6.2.

CERTAIN FOREIGN PAYMENTS. Notwithstanding the provisions of Section 3.2, if any therapeutic Human Healthcare Product is not approved for sale in the United States, but is approved for sale in any other country, payments shall be made to the Limited Partner in respect of such product in such country at one-half the rates set forth in Section 3.2; provided, however, that payments of the type described in Section 3.2(c) shall be amortized over a five year period from the date of the payment and paid only for months before the month in which foreign payments in respect of the product become no longer payable. However, once such therapeutic Human Healthcare Product is approved for sale in the United States, all payments in respect of such product in countries other than the United States shall cease, and payments shall be made solely in respect of such product in the United States; provided, however, that in the case of Interleukin-2, the payments described in the first sentence of this Section 3.3 shall continue until such time as payments to the Limited Partner in respect of United States sales by Cetus and United States sublicensing and other payments received by Cetus in respect of Interleukin-2 for any quarter equal or exceed the payments made by Cetus to the Limited Partner in respect of foreign sales made by Cetus and foreign sublicensing and other payments received by Cetus in respect of Interleukin-2 for the quarter in which FDA approval to market the product was granted.

CERTAIN FOREIGN PAYMENTS. If governmental regulations prevent remittance from any foreign country of any amounts due under Section 3 in respect of that country, Licensee shall so notify Licensor in writing, and the obligation under this Agreement to make payments in respect of sales in that country shall be suspended (but the amounts due but not paid shall continue to accrue) until such remittances are possible. Licensor shall have the right, upon written notice to Licensee, to receive payment in any such country in the local currency.